Clinton, MS, United States of America

Scoty Hearst

This inventor holds 1 USPTO granted patent. Top assignee: Parminder J. S. Vig. Active years: 2016.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scoty Hearst: Innovator in Neurodegenerative Disease Treatment

Introduction

Scoty Hearst is a notable inventor based in Clinton, MS (US). He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and patent.

Latest Patents

Scoty Hearst holds a patent for "Composition and methods for targeted delivery of a therapeutic compound to the brain or spinal cord of a subject for treatment of neurodegenerative diseases." This patent focuses on compositions that target specific regions of the brain or spinal cord, incorporating a therapeutic compound, a cell-penetrating peptide (CPP), and a thermal targeting polypeptide (TTP). His work is crucial for advancing treatment options for patients suffering from neurodegenerative conditions.

Career Highlights

Throughout his career, Scoty Hearst has demonstrated a commitment to innovation in medical science. His patent reflects his dedication to improving therapeutic strategies and enhancing the efficacy of treatments for complex neurological disorders.

Collaborations

Scoty collaborates with esteemed colleagues, including Parminder J. S. Vig and Drazen Raucher. Their combined expertise fosters a productive research environment that drives forward the development of new therapeutic approaches.

Conclusion

Scoty Hearst's contributions to the field of neurodegenerative disease treatment through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…